GP2

Drug

Related News

Greenwich LifeSciences Receives Second Nasdaq Notice for Late SEC Filing

May 23, 2026

Greenwich LifeSciences received a second Nasdaq notice for late filing of its Form 10-Q, following a prior notice for a late Form 10-K. The company's stock continues trading on the Nasdaq Capital Market while it works to file the overdue reports.

Greenwich LifeSciences Announces Two Abstracts Accepted at AACR Annual Meeting 2026

Feb 25, 2026

Greenwich LifeSciences announced acceptance of two abstracts for presentation at the AACR Annual Meeting 2026, including the first abstract co-authored with the full FLAMINGO-01 Steering Committee. The conference will be held April 17-22, 2026.